Impact of palivizumab on expected costs of respiratory syncytial virus infection in preterm infants: Potential for savings

Asthma and Wheezing in the First Six Years of Life

Fernando D. Martínez, Anne L. Wright, Lynn M. Taussig et al. · New England Journal of Medicine · 1995 · 3.8K citations · Full text

Medicine, Child Health, Pediatrics +13

Palivizumab, a Humanized Respiratory Syncytial Virus Monoclonal Antibody, Reduces Hospitalization From Respiratory Syncytial Virus Infection in High-risk Infants

PEDIATRICS · 1998 · 1.9K citations

Pharmacy, Pediatrics, Pharmacotherapy +16

Prophylactic Administration of Respiratory Syncytial Virus Immune Globulin to High-Risk Infants and Young Children

Jessie R. Groothuis, Eric A. F. Simões, Myron J. Levin et al. · New England Journal of Medicine · 1993 · 747 citations · Full text

Medicine, Infectious Diseases, Pediatrics +17

Wheezing, asthma, and pulmonary dysfunction 10 years after infection with respiratory syncytial virus in infancy.

C R Pullan, Edmund Hey · BMJ · 1982 · 605 citations · Full text

Medicine, Child Health, Pediatrics +16

Reduction of Respiratory Syncytial Virus Hospitalization Among Premature Infants and Infants With Bronchopulmonary Dysplasia Using Respiratory Syncytial Virus Immune Globulin Prophylaxis

PEDIATRICS · 1997 · 451 citations

Medicine, Infectious Diseases, Pediatrics +14